Bio-Techne Corp
TECH65.700USD
+1.120+1.73%
Handelsschluss 01/09, 16:00（ET）Kurse um 15 Minuten verzögert
10.23BMarktkapitalisierung
131.56KGV TTM
mehr Informationen über Bio-Techne Corp Unternehmen
Bio-Techne Corporation develop, manufacture and sell life science reagents, instruments and services for the research, diagnostics and bioprocessing markets worldwide. The Company’s segments include Protein Sciences segment and Diagnostics and Spatial Biology segment. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, advanced tissue-based in-situ hybridization assays and instrumentation for spatial genomic and tissue biopsy analysis and genetic and oncology kits for research and clinical applications. Its product portfolio and application enable scientific investigations into biological processes and molecular diagnostics and progression of specific diseases.
Bio-Techne Corp Informationen
BörsenkürzelTECH
Name des UnternehmensBio-Techne Corp
IPO-datumFeb 09, 1989
CEOKelderman (Kim)
Anzahl der mitarbeiter3100
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 09
Addresse614 Mckinley Pl N E
StadtMINNEAPOLIS
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl55413
Telefon16123798854
Websitehttps://www.bio-techne.com/
BörsenkürzelTECH
IPO-datumFeb 09, 1989
CEOKelderman (Kim)
Führungskräfte von Bio-Techne Corp
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. John L. Higgins
Mr. John L. Higgins
Independent Director
Independent Director
66.88K
+1640.00%
Mr. Kim Kelderman
Mr. Kim Kelderman
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
48.66K
-2303.00%
Mr. Robert V. (Bob) Baumgartner, CPA
Mr. Robert V. (Bob) Baumgartner, CPA
Independent Chairman of the Board
Independent Chairman of the Board
46.50K
+1640.00%
Dr. Joseph D. (Joe) Keegan, Ph.D.
Dr. Joseph D. (Joe) Keegan, Ph.D.
Independent Director
Independent Director
15.41K
+1640.00%
Dr. Rupert J. Vessey, Ph.D.
Dr. Rupert J. Vessey, Ph.D.
Independent Director
Independent Director
10.99K
+1640.00%
Ms. Julie L. Bushman
Ms. Julie L. Bushman
Independent Director
Independent Director
8.78K
+1640.00%
Mr. Shane Bohnen
Mr. Shane Bohnen
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
4.38K
--
Dr. Judith V. Klimovsky, M.D.
Dr. Judith V. Klimovsky, M.D.
Independent Director
Independent Director
3.78K
+1640.00%
Mr. James T. (Jim) Hippel
Mr. James T. (Jim) Hippel
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
--
--
Mr. David Clair
Mr. David Clair
Investor Relations
Investor Relations
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. John L. Higgins
Mr. John L. Higgins
Independent Director
Independent Director
66.88K
+1640.00%
Mr. Kim Kelderman
Mr. Kim Kelderman
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
48.66K
-2303.00%
Mr. Robert V. (Bob) Baumgartner, CPA
Mr. Robert V. (Bob) Baumgartner, CPA
Independent Chairman of the Board
Independent Chairman of the Board
46.50K
+1640.00%
Dr. Joseph D. (Joe) Keegan, Ph.D.
Dr. Joseph D. (Joe) Keegan, Ph.D.
Independent Director
Independent Director
15.41K
+1640.00%
Dr. Rupert J. Vessey, Ph.D.
Dr. Rupert J. Vessey, Ph.D.
Independent Director
Independent Director
10.99K
+1640.00%
Ms. Julie L. Bushman
Ms. Julie L. Bushman
Independent Director
Independent Director
8.78K
+1640.00%
Umsatzaufteilung
Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Consumables
231.60M
80.82%
Service
27.48M
9.59%
Instruments
21.83M
7.62%
Royalty
5.65M
1.97%
Nach RegionUSD
Name
Umsatz
Anteil
United States
155.24M
54.17%
EMEA, excluding U.K
65.13M
22.73%
Greater China
24.79M
8.65%
APAC, excluding Greater China
19.15M
6.68%
United Kingdom
13.21M
4.61%
Rest of World
9.05M
3.16%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Consumables
231.60M
80.82%
Service
27.48M
9.59%
Instruments
21.83M
7.62%
Royalty
5.65M
1.97%
Aktionärsstatistik
Aktualisiert: Sun, Nov 16
Aktualisiert: Sun, Nov 16
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
11.48%
BlackRock Institutional Trust Company, N.A.
5.64%
State Street Investment Management (US)
3.69%
Wellington Management Company, LLP
3.28%
Atlanta Capital Management Company, L.L.C.
3.17%
Andere
72.73%
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
11.48%
BlackRock Institutional Trust Company, N.A.
5.64%
State Street Investment Management (US)
3.69%
Wellington Management Company, LLP
3.28%
Atlanta Capital Management Company, L.L.C.
3.17%
Andere
72.73%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
58.57%
Investment Advisor/Hedge Fund
34.00%
Hedge Fund
8.06%
Bank and Trust
2.18%
Research Firm
1.96%
Pension Fund
1.35%
Sovereign Wealth Fund
1.24%
Individual Investor
0.28%
Insurance Company
0.24%
Institutionelle Beteiligung
Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
1201
167.79M
107.68%
+389.22K
2025Q3
1198
161.18M
103.53%
-7.34M
2025Q2
1209
165.25M
105.41%
-730.33K
2025Q1
1245
168.10M
107.22%
+1.54M
2024Q4
1233
162.21M
102.61%
-6.39M
2024Q3
1205
159.40M
100.49%
-10.21M
2024Q2
1207
160.52M
101.86%
-12.24M
2024Q1
1216
162.56M
103.40%
-7.57M
2023Q4
1229
159.70M
100.98%
-3.97M
2023Q3
1217
156.41M
98.84%
-7.93M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
17.89M
11.48%
-504.17K
-2.74%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
8.79M
5.64%
-7.47K
-0.08%
Sep 30, 2025
State Street Investment Management (US)
5.75M
3.69%
-105.19K
-1.80%
Sep 30, 2025
Wellington Management Company, LLP
5.12M
3.28%
+3.98M
+349.84%
Sep 30, 2025
Atlanta Capital Management Company, L.L.C.
4.94M
3.17%
+646.77K
+15.06%
Sep 30, 2025
Geode Capital Management, L.L.C.
4.93M
3.16%
+864.67K
+21.28%
Sep 30, 2025
Invesco Capital Management LLC
3.51M
2.26%
+275.06K
+8.49%
Sep 30, 2025
Neuberger Berman, LLC
3.31M
2.12%
+807.15K
+32.29%
Sep 30, 2025
T. Rowe Price Associates, Inc.
3.12M
2%
-5.50M
-63.78%
Sep 30, 2025
Maverick Capital, Ltd.
3.01M
1.93%
+3.01M
--
Sep 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Global X Genomics & Biotechnology ETF
4.29%
Invesco Biotechnology & Genome ETF
2.92%
Invesco S&P 500 Equal Weight Health Care ETF
2%
Neuberger Berman Small-Mid Cap ETF
1.78%
VanEck Biotech ETF
1.73%
Hilton Small-MidCap Opportunity ETF
1.7%
iShares Health Innovation Active ETF
1.68%
American Century Mid Cap Growth Impact ETF
1.47%
Thrivent Small-Mid Cap ESG ETF
1.34%
Invesco S&P 500 High Beta ETF
1.06%
Mehr Anzeigen
Global X Genomics & Biotechnology ETF
Anteil4.29%
Invesco Biotechnology & Genome ETF
Anteil2.92%
Invesco S&P 500 Equal Weight Health Care ETF
Anteil2%
Neuberger Berman Small-Mid Cap ETF
Anteil1.78%
VanEck Biotech ETF
Anteil1.73%
Hilton Small-MidCap Opportunity ETF
Anteil1.7%
iShares Health Innovation Active ETF
Anteil1.68%
American Century Mid Cap Growth Impact ETF
Anteil1.47%
Thrivent Small-Mid Cap ESG ETF
Anteil1.34%
Invesco S&P 500 High Beta ETF
Anteil1.06%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
250.90M
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Nov 05, 2025
TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Nov 28, 2025 going ex on Nov 17, 2025
Nov 17, 2025
Nov 28, 2025
Nov 17, 2025
Aug 06, 2025
TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Aug 29, 2025 going ex on Aug 18, 2025
Aug 18, 2025
Aug 29, 2025
Aug 18, 2025
May 07, 2025
TECH.NB Interim Cash Dividend of gross USD 0.08 paid on May 30, 2025 going ex on May 19, 2025
May 19, 2025
May 30, 2025
May 19, 2025
Feb 05, 2025
TECH.NB Final Cash Dividend of gross USD 0.08 paid on Feb 28, 2025 going ex on Feb 14, 2025
Feb 17, 2025
Feb 28, 2025
Feb 14, 2025
Oct 30, 2024
TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Nov 22, 2024 going ex on Nov 08, 2024
Nov 11, 2024
Nov 22, 2024
Nov 08, 2024
Aug 07, 2024
TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Aug 30, 2024 going ex on Aug 19, 2024
Aug 19, 2024
Aug 30, 2024
Aug 19, 2024
May 01, 2024
TECH.NB Interim Cash Dividend of gross USD 0.08 paid on May 24, 2024 going ex on May 10, 2024
May 13, 2024
May 24, 2024
May 10, 2024
Feb 01, 2024
TECH.NB Final Cash Dividend of gross USD 0.08 paid on Feb 26, 2024 going ex on Feb 09, 2024
Feb 12, 2024
Feb 26, 2024
Feb 09, 2024
Oct 31, 2023
TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Nov 24, 2023 going ex on Nov 09, 2023
Nov 10, 2023
Nov 24, 2023
Nov 09, 2023
Aug 08, 2023
TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Sep 01, 2023 going ex on Aug 17, 2023
Aug 18, 2023
Sep 01, 2023
Aug 17, 2023
Mehr Anzeigen
Aktien-Split
Datum
Art
Verhältnis
Nov 01, 2022
Split
1→4
Datum
Art
Verhältnis
Nov 01, 2022
Split
1→4
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Bio-Techne Corp?
Die fünf größten Anteilseigner von Bio-Techne Corp sind:
The Vanguard Group, Inc. hält 17.89M Aktien, was 11.48% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 8.79M Aktien, was 5.64% der Gesamtaktien entspricht.
State Street Investment Management (US) hält 5.75M Aktien, was 3.69% der Gesamtaktien entspricht.
Wellington Management Company, LLP hält 5.12M Aktien, was 3.28% der Gesamtaktien entspricht.
Atlanta Capital Management Company, L.L.C. hält 4.94M Aktien, was 3.17% der Gesamtaktien entspricht.
The Vanguard Group, Inc. hält 17.89M Aktien, was 11.48% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 8.79M Aktien, was 5.64% der Gesamtaktien entspricht.
State Street Investment Management (US) hält 5.75M Aktien, was 3.69% der Gesamtaktien entspricht.
Wellington Management Company, LLP hält 5.12M Aktien, was 3.28% der Gesamtaktien entspricht.
Atlanta Capital Management Company, L.L.C. hält 4.94M Aktien, was 3.17% der Gesamtaktien entspricht.
Was sind die drei wichtigsten Anteilseigner-Typen von Bio-Techne Corp?
Die drei wichtigsten Anteilseigner-Typen von Bio-Techne Corp sind:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
Wie viele Institutionen halten Anteile an Bio-Techne Corp (TECH)?
Mit Stand vom 2025Q4 halten 1201 Institutionen Anteile an Bio-Techne Corp, mit einem Gesamtmarktwert von etwa 167.79M, was 107.68% der Gesamtanteile entspricht. Im Vergleich zum 2025Q3 ist der institutionelle Aktienbesitz um 4.16% gestiegen.
Was ist die größte Einnahmequelle von Bio-Techne Corp?
Am FY2026Q1 erzielte das Geschäft mit Consumables für Bio-Techne Corp den höchsten Umsatz in Höhe von 231.60M, was 80.82% des Gesamtumsatzes entspricht.
